Welcome to LookChem.com Sign In|Join Free
  • or
Beijing Cooperate Pharmaceutical Co.,LtdSupply fresh GW501516 /Cardarine|Cas 317318-70-0|GW1516|Competitive//www.lookchem.com/300w/2010/0620/317318-70-0.jpg
qq

Communicate with Supplier:

Ms. ivy tang
Ms. ivy tang: What can I do for you?

Supply fresh GW501516 /Cardarine|Cas 317318-70-0|GW1516|Competitive CAS NO.317318-70-0

Min.Order Quantity:
10 Gram
Purity:
99%
Port:
beijing,shanghai
Payment Terms:
L/C,T/T,MoneyGram

Add to Inquiry Cart

Product Details

Keywords

  • 317318-70-0
  • Cardarine low price
  • GW-501516 high quality

Quick Details

  • ProName: Supply fresh GW501516 /Cardarine|Cas 3...
  • CasNo: 317318-70-0
  • Molecular Formula: C21H18F3NO3S2
  • Appearance: White crystalline powder
  • Application: Pharmaceutical Intermediate
  • DeliveryTime: 4-7days
  • PackAge: bag
  • Port: beijing,shanghai
  • ProductionCapacity: 50kg Kilogram/Month
  • Purity: 99%
  • Storage: Shading, Confined Preservation
  • Transportation: FedEx, DHL, EMS or by Sea
  • LimitNum: 10 Gram

Superiority

gw501516
product name:supply fresh gw501516 /cardarine 99% cas 317318-70-0 gw1516
cas:317318-70-0
molecular formula:c21h18f3no3s2
molecular weight:453.498
assay:99% usp32
appearance:white crystalline powder

1.100% ensure quality and shipping service.

2.sample is available.

3.bulk price with high qualiy you will get.

Details

gw 501516 (cardarine) is one of the most versatile performance enhancers one will ever come across.
whether you are looking to drastically increase endurance, melt fat, cut or recomp, gw will truly shine. in this article, i am going to touch on the many ways and reason to incorporate gw into every cycle that you run. there is a place for gw in every cycle, regardless of the desired goal. it can only add extra benefits that will further enhance the chances of accomplishing goals and maximizing gains

gw-501516 is a unique medication officially classified as a ppar receptor agonist (ppar-ra). research for this medication began in 1992 in a conjoined effort between glaxosmithkline (gsk) and ligand pharmaceuticals. research into this product was set forth in an effort to provide treatment for various cardiovascular diseases, as well as diabetes, obesity and other conditions. it was soon discovered that the ppar-ra was highly effective at enhancing endurance, but it was also shown to carry a high potential cost. it was discovered that gw-501516 increased the chances of cancer significantly, and as a result, gsk dropped all further research. however, the studies that produced cancerous results used doses of gw-501516 that were 500 to even 1000 times the amount that a human being would take. if cancer is a risk with standard dosing is unknown.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)